Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats
Authors:
- Iveta GradosovaIGIveta Gradosova
- Helena ZivnaHZHelena Zivna
- Vladimir PalickaVPVladimir Palicka
- Sona HubenaSHSona Hubena
- Klara SvejkovskaKSKlara Svejkovska
- Pavel ZivnyPZPavel Zivny
- 1 March 2012
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 679 (1-3) , 144-150
Abstract
No abstract availableKeywords
Funding Information
- Research Project of the Czech Ministry of Health (MZO 00179906)
- Charles University in Prague project (SVV-2011-262902)
This publication has 24 references indexed in Scilit:
- Update in New Anabolic Therapies for OsteoporosisThe Journal of Clinical Endocrinology & Metabolism, 2010
- Bone turnover markers in the management of postmenopausal osteoporosisClinical Biochemistry, 2009
- Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With MicroalbuminuriaDiabetes Care, 2007
- Statins and fracture risk. A systematic reviewPharmacoepidemiology and Drug Safety, 2007
- Statins and osteoporosis: new role for old drugsJournal of Pharmacy and Pharmacology, 2006
- Atorvastatin stimulates the production of osteoprotegerin by human osteoblastsJournal of Cellular Biochemistry, 2005
- Changes in receptor activator of nuclear factor‐kappaB, and its ligand, osteoprotegerin, bone‐type alkaline phosphatase, and tartrate‐resistant acid phosphatase in ovariectomized ratsJournal of Cellular Biochemistry, 2004
- The Ability of Statins to Inhibit Bone Resorption Is Directly Related to Their Inhibitory Effect on HMG-CoA Reductase ActivityJournal of Bone and Mineral Research, 2003
- RANK Ligand and OsteoprotegerinArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999